Sep 1, 1977

Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections

Annals of Internal Medicine
J G KaneP D Hoeprich

Abstract

The nafcillin concentration of simultaneous cerebrospinal fluid (CSF) and serum specimens from nine patients being treated with parenteral nafcillin for staphylococcal infection were measured. Marked variations in the ratio of CSF/serum nafcillin concentration were observed. However, the concentration of nafcillin in the CSF was greater than the minimum lethal concentration (MLC) for Staphylococcus aureus in eight of the nine patients. In five patients with CSF pleocytosis, the nafcillin concentration was three to 100 times the MLC. These results support the recommendation to use nafcillin in doses of at least 100 to 200 mg/kg body weight-day for treatment of meningitis caused by S. aureus.

  • References
  • Citations8

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations8

Citations

Mentioned in this Paper

Nafcillin
Leukocytosis
Thylacodes aureus
Weighing Patient
Cerebrospinal Fluid
Staphylococcal Infections
Etiology
Styrax aureus
Packera aurea
Sericulus aureus

About this Paper

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.